SAN FRANCISCO, July 23, 2019 /PRNewswire/ -- pMD, the innovation leader in health care technology, today announced a free HIPAA-compliant communication platform to better connect  providers with

RARITAN, N.J., July 23, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced the CE Mark of an enhanced version of its VITROS® NT-proBNP II assay, part of Ortho's expansive cardiac menu. The analytical characteristics and clinical performance of the VITROS NT-proBNP II assay allow clinicians to efficientl

NEW YORK, July 23, 2019 /PRNewswire/ -- Patient Innovations is proud to announce that Jeffrey D. Alter, President of Arcturus One Consulting, and

CARLSBAD, Calif., July 23, 2019 /PRNewswire/ -- Oska Wellness, a pioneer of technology-driven wellness solutions, today released findings from its

ST. LOUIS, July 23, 2019 /PRNewswire/ -- Lumeris, an industry leader in value-based care, today announced that the National Committee for Quality Assurance (NCQA) Review Oversight Committee has awarded the company Accreditation status for Case Management and Utilization Management. In addition, Lumeris also earned Certification as an NCQA Credentials Verification Or

DETROIT, July 23, 2019 /PRNewswire/ - Patients with herniated discs in the Detroit area now have expanded options for spine surgery. Dr. Nilesh Patel now offers herniated disc repair utilizing the AnchorKnot® Tissue Approximation Kit. Microdiscectomy techniques offer surgical decompression of

REDWOOD SHORES, Calif., July 23, 2019 /PRNewswire/ -- Oracle Health Sciences was positioned as a Leader and the highest scoring vendor in Vision and Capability in the Everest Group PEAK Matrix™ 2019 Assessment of Life Sciences Clinical Trials Products. Everest Group assesses vendors based on their market impact (market adoption, value delivered and portfolio mix) and vision and capabilit

NEW YORK, July 23, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") announced today that the 75th patient has been treated in the pivotal Phase 3 SIERRA trial of Iomab-B, thus achieving 50 percent patient enrollment for the trial.

ST. LOUIS, July 23, 2019 /PRNewswire/ -- Sandberg Phoenix launched SPIN, a collaborative solution with IT experts focused on HIPAA and MACRA/MIPS and O

SOUTH PLAINFIELD, N.J., July 23, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2019 financial results and provide an update on the company's business and outlook on Tuesday, August 6, 2019 at 4:30 p.m. (E